Equities
Basic MaterialsIndustrial Metals
  • Price (GBX)341.70
  • Today's Change-15.50 / -4.34%
  • Shares traded1.25m
  • 1 Year change-28.95%
  • Beta2.1246
Data delayed at least 20 minutes, as of Dec 05 2019 14:58 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year EVRAZ plc grew revenues 18.56% from 10.83bn to 12.84bn while net income improved 244.21% from 699.00m to 2.41bn.
Gross margin35.11%
Net profit margin13.21%
Operating margin21.01%
Return on assets17.22%
Return on equity81.62%
Return on investment23.02%
More ▼

Cash flow in USDView more

In 2018, cash reserves at EVRAZ plc fell by 399.00m. However, the company earned 2.63bn from its operations for a Cash Flow Margin of 20.51%. In addition the company used 378.00m on investing activities and also paid 2.61bn in financing cash flows.
Cash flow per share1.15
Price/Cash flow per share3.07
Book value per share1.07
Tangible book value per share0.4983
More ▼

Balance sheet in USDView more

EVRAZ plc has a Debt to Total Capital ratio of 66.27%, a lower figure than the previous year's 230.34%.
Current ratio1.67
Quick ratio0.9384
Total debt/total equity2.21
Total debt/total capital0.6627
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.